GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (OTCPK:CXXIF) » Definitions » Debt-to-Asset

CXXIF (C21 Investments) Debt-to-Asset : 0.23 (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is C21 Investments Debt-to-Asset?

C21 Investments's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $2.58 Mil. C21 Investments's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $10.90 Mil. C21 Investments's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was $57.81 Mil. C21 Investments's debt to asset for the quarter that ended in Dec. 2024 was 0.23.


C21 Investments Debt-to-Asset Historical Data

The historical data trend for C21 Investments's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments Debt-to-Asset Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 0.59 0.39 0.30 0.21

C21 Investments Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Jun24 Sep24 Dec24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.20 0.22 0.24 0.23

Competitive Comparison of C21 Investments's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where C21 Investments's Debt-to-Asset falls into.


;
;

C21 Investments Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

C21 Investments's Debt-to-Asset for the fiscal year that ended in Jan. 2023 is calculated as

C21 Investments's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(2.575 + 10.898) / 57.811
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


C21 Investments  (OTCPK:CXXIF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


C21 Investments Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of C21 Investments's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 170, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles.

C21 Investments Headlines

From GuruFocus

C21 Expands Oregon Operations, Acquires Swell Companies Limited

By PRNewswire PRNewswire 07-09-2018

C21's Nevada Dispensaries Achieve Record Retail Revenue for Q2

By PRNewswire PRNewswire 08-04-2020

C21 Investments Announces Q2 Results

By PRNewswire PRNewswire 09-24-2020

C21 Investments granted first CBD licence issued in Ukraine

By PRNewswire PRNewswire 11-07-2018

C21 Investments Announces Q3 Results

By PRNewswire PRNewswire 12-16-2020

C21 Investments Announces Q1 Results

By PRNewswire PRNewswire 08-13-2020

Year-End Letter to Shareholders

By PRNewswire PRNewswire 02-10-2020